New research is disputing a long-held claim that speedier drug approvals inevitably lead to increased health and safety warnings by regulators. A study concludes there is no proof haste makes waste in drug regulation: “Safety warnings are safety warnings.”
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
